Watch Ticker

MeiraGTx Holdings plc Ordinary Shares

Go to MeiraGTx Holdings plc Ordinary Shares Website

$7.74

-0.10 (-1.28%)

Live

Previous Close

$7.84

Day Range

$7.67 - $7.9521

Previous Day Range

$7.65 - $7.97

Market Cap

$614.8 million USD

Day Vol.

251942

Previous Day Vol.

414190

Currency

USD

Primary Exchange

Nasdaq

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it ope...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

A comprehensive analysis reveals over 70 companies developing AAV gene therapies for hereditary retinal diseases, offering potential transformative treatments for vision restoration through advanced gene therapy techniques.

Related tickers: NVS, JNJ, OCGN, MGTX.

Read Full Article

N/A - Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases

Coave Therapeutics, a company pioneering genetic medicines, has established a new Scientific Advisory Board (SAB) with renowned experts in AAV vector biology, gene therapy for ophthalmology and CNS diseases, and extra-hepatic gene delivery. The SAB will provide strategic guidance to support Coave's R&D initiatives and the development of its ALIGATER platform.

Related tickers: RGNX, MGTX.

Read Full Article

Trending Tickers

Please sign in to view